We are proud of the department's long history of cutting edge investigation in all types of health science research. While our investigators continue to pursue substantial bench research, we have been expanding our focus in the areas of translational and clinical research.
A $1 million investment will launch two physician-led clinical research efforts in North Carolina to grow medical knowledge by seeking to answer pressing questions.
The pair of $500,000 research grants focusing on urgent health needs marks the largest single investment awarded by the collaborative involving Novant Health, UNC Health and the University of North Carolina at Chapel Hill School of Medicine. The funding will launch joint Novant Health and UNC School of Medicine studies focusing on treatments for patients with pediatric asthma and advanced prostate cancer.
Eveline Wu, MD, MSCR, Associate Professor and Division Chief of Pediatric Rheumatology in the Department of Pediatrics, is one of 14 researchers nationwide selected to receive the award this year.
The UNC site lead investigators are Edwin Kim, MD, associate professor of medicine, division chief of UNC Pediatric Allergy & Immunology, and Corinne Keet, MD, PhD, professor of pediatrics, vice chair of clinical and translational research.
Vanderbilt University Medical Center is launching a first-in-human clinical trial to determine the safety and efficacy of an experimental monoclonal antibody against enterovirus D68 (EV-D68). UNC School of Medicine’s Matthew Vogt, MD, PhD, was a postdoctoral fellow in Pediatric Infectious Diseases at VUMC when he co-led the development of monoclonal antibody therapies against EV-D68.